About Contact Us Careers
Sign In

Infectious Disease Therapeutics Market Market - Top Companies and Manufacturers

  • Report ID: 6407
  • Published Date: Sep 10, 2024
  • Report Format: PDF, PPT

Companies Dominating the Infectious Disease Therapeutics Landscape

    The strong presence and result-driven approach toward an effective healthcare system across the globe by pharmaceutical companies is shaping the environment for the infectious disease therapeutics market. Key players are focused on developing novel drugs and therapeutics to cater to rising burden of various infectious diseases. Some research institutes are also partnering with companies to assist in R&D projects while some companies are adopting several techniques such as mergers and acquisitions, joint ventures, product launches, and license agreements to enhance their product base and retain their market position. Here are some leading key players operating in the infectious disease therapeutics market:

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GlaxoSmithKline plc.
    •  Merck & Co.
    • F. Hoffmann-La Roche Ltd
    • AstraZeneca
    • Sun Pharma Industries Ltd.
    • Cipla Ltd.
Browse Key Market Insights with Data Illustration:

In the News

  • In April 2024, AstraZeneca showcased its new clinical, real-world, and early science data across its Vaccines & Immune Therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Barcelona, Spain.
  • In September 2023, Moderna announced the expansion of its mRNA medicine for rare diseases, cancer, and infectious diseases.

Author Credits:  Radhika Pawar


  • Report ID: 6407
  • Published Date: Sep 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of the infectious disease therapeutics market is estimated to be over USD 124.5 billion.

The market size of the infectious disease therapeutics market is projected to cross USD 188.1 billion by the end of 2037 expanding at a CAGR of 3.5% during the forecast period i.e., between 2025–2037.

The major players in the market are Pfizer Inc, GlaxoSmithKline, plc, Merck & Co., F. Hoffmann-La Roche Ltd, AstraZeneca, Mylan N.V., Novartis AG, Sanofi and others.

In terms of the distribution channel segment, the hospital is anticipated to garner the largest market share of 55.1% during 2025-2037.

The market in North America is projected to hold the largest market share of 42.1% in 2024 and is likely to expand by the end of 2037 to provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample